Implementation of Two Novel Interdisciplinary Care Models and the Impact on Hepatitis C Treatment Uptake, Completion and Sustained Virologic Response

Grants and Contracts Details

StatusActive
Effective start/end date3/12/1811/10/23

Funding

  • Gilead Sciences Inc: $1,833,754.00